Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Reduction in HTLV-I proviral load and spontaneous lymphoproliferation in HTLV-I-associated myelopathy/tropical spastic paraparesis patients treated with humanized anti-Tac.
Lehky TJ, Levin MC, Kubota R, Bamford RN, Flerlage AN, Soldan SS, Leist TP, Xavier A, White JD, Brown M, Fleisher TA, Top LE, Light S, McFarland HF, Waldmann TA, Jacobson S. Lehky TJ, et al. Among authors: top le. Ann Neurol. 1998 Dec;44(6):942-7. doi: 10.1002/ana.410440613. Ann Neurol. 1998. PMID: 9851439
Preclinical and phase I clinical trial of blockade of IL-15 using Mikbeta1 monoclonal antibody in T cell large granular lymphocyte leukemia.
Morris JC, Janik JE, White JD, Fleisher TA, Brown M, Tsudo M, Goldman CK, Bryant B, Petrus M, Top L, Lee CC, Gao W, Waldmann TA. Morris JC, et al. Proc Natl Acad Sci U S A. 2006 Jan 10;103(2):401-6. doi: 10.1073/pnas.0509575103. Epub 2005 Dec 30. Proc Natl Acad Sci U S A. 2006. PMID: 16387851 Free PMC article. Clinical Trial.
Radioimmunotherapy of interleukin-2R alpha-expressing adult T-cell leukemia with Yttrium-90-labeled anti-Tac.
Waldmann TA, White JD, Carrasquillo JA, Reynolds JC, Paik CH, Gansow OA, Brechbiel MW, Jaffe ES, Fleisher TA, Goldman CK, Top LE, Bamford R, Zaknoen E, Roessler E, Kasten-Sportes C, England R, Litou H, Johnson JA, Jackson-White T, Manns A, Hanchard B, Junghans RP, Nelson DL. Waldmann TA, et al. Among authors: top le. Blood. 1995 Dec 1;86(11):4063-75. Blood. 1995. PMID: 7492762 Free article. Clinical Trial.
The interleukin-2 receptor: a target for immunotherapy.
Waldmann TA, Goldman C, Top L, Grant A, Burton J, Bamford R, Roessler E, Horak I, Zaknoen S, Kasten-Sportes C, et al. Waldmann TA, et al. Ann N Y Acad Sci. 1993 Jun 23;685:603-10. doi: 10.1111/j.1749-6632.1993.tb35923.x. Ann N Y Acad Sci. 1993. PMID: 8363269 Review. No abstract available.
The interleukin-2 receptor: a target for immunotherapy.
Waldmann TA, Goldman C, Top L, Grant A, Burton J, Bamford R, Roessler E, Horak I, Zaknoen S, Kasten-Sportes C, et al. Waldmann TA, et al. Adv Exp Med Biol. 1992;323:57-66. doi: 10.1007/978-1-4615-3396-2_8. Adv Exp Med Biol. 1992. PMID: 1485565 Review. No abstract available.
The combination of zidovudine and interferon alpha-2B in the treatment of adult T-cell leukemia/lymphoma.
White JD, Wharfe G, Stewart DM, Maher VE, Eicher D, Herring B, Derby M, Jackson-Booth PG, Marshall M, Lucy D, Jain A, Cranston B, Hanchard B, Lee CC, Top LE, Fleisher TA, Nelson DL, Waldmann TA. White JD, et al. Among authors: top le. Leuk Lymphoma. 2001 Jan;40(3-4):287-94. doi: 10.3109/10428190109057927. Leuk Lymphoma. 2001. PMID: 11426550 Clinical Trial.
Immunization with mutant p53- and K-ras-derived peptides in cancer patients: immune response and clinical outcome.
Carbone DP, Ciernik IF, Kelley MJ, Smith MC, Nadaf S, Kavanaugh D, Maher VE, Stipanov M, Contois D, Johnson BE, Pendleton CD, Seifert B, Carter C, Read EJ, Greenblatt J, Top LE, Kelsey MI, Minna JD, Berzofsky JA. Carbone DP, et al. Among authors: top le. J Clin Oncol. 2005 Aug 1;23(22):5099-107. doi: 10.1200/JCO.2005.03.158. Epub 2005 Jun 27. J Clin Oncol. 2005. PMID: 15983396 Free article. Clinical Trial.
18 results